- Guide to PHARMACOLOGY
Synonyms: BCX-1777 | BCX1777 | Fodosine® (proposed trade name) | immucillin H | immucillin-H
Compound class: Synthetic organic
Comment: Forodesine is a picomolar inhibitor of purine nucleoside phosphorylase (PNP) [1,4].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|No information available.|
|Summary of Clinical Use|
|The EMA has granted orphan drug designation to forodesine and forodesine hydrochloride for the treatment of acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and cutaneous T cell lymphoma. Forodesine has reached Phase II clinical trial for these indications.|
|Mechanism Of Action and Pharmacodynamic Effects|
|Forodesine inhibits the growth of malignant T cell leukemia cells and induces apoptosis .|